Wednesday, 19 June 2013
increase font size
Latest news
UK Health Protection Agency: Biannual CJD update (2011/12)
Health Protection Agency: Biannual CJD update (2011/12)
Summary of 29 Oct. meeting (Advisory Committee on the Safety of Blood, Tissues and Organs)
CJD blood filter call for under-13s (26 Nov. 2009)
Mapping out the consequences of screening blood donations for PrPSc (17 Feb. 2009, UK DOH)
UK Health Protection Agency: vCJD abnormal prion protein found in a patient with haemophilia at post mortem (17 Feb. 2009)
UK Health Protection Agency - CJD homepage
Screening blood donors for vCJD "unrealistic" says Safety of Blood Tissues and Organs advisory committee (20 Oct. 2008)
Potential risk of variant Creutzfeldt-Jakob Disease (vCJD) from plasma-derived products
Listed by date published (newest first)
Bellingham SA, Coleman BM, Hill AF. Small RNA deep sequencing reveals a distinct miRNA signature released in exosomes from prion-infected neuronal cells. Nucl Acids Res 2012. (Pub. online: 10 Sept. 2012) Full free text
Clewley JP, et al. Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey. BMJ 2009 May21;338:b1442.
Kaski D, et al. Variant CJD in an individual heterozygous for PRNP codon 129. The Lancet 2009 Dec 19;374(9707): 2128.
Lefrère J-J, Hewitt P. From mad cows to sensible blood transfusion: the risk of prion transmission by labile blood components in the United Kingdom and in France. Transfusion 2009; 49(4):797812.
Coste J, Prowse C, Eglin R, Fang C; for the Subgroup on TSE. A report on transmissible spongiform encephalopathies and transfusion safety. Vox Sang 2009 Feb 10. [Epub ahead of print]
Dietz K, et al. Blood transfusion and spread of variant Creutzfeldt-Jakob disease. Emerging Infectious Diseases 2007 Jan; 13(1).
Editors. Fourth case of transfusion-associated vCJD infection in the United Kingdom.Euro Surveill. 2007 Jan 18;12(1).
Houston F, McCutcheon S, Goldmann W, Chong A, Foster J, Siso S, et al. Prion diseases are efficiently transmitted by blood transfusion in sheep. Blood 2008 Jul 22. [Epub ahead of print]
Millar CM, Connor N, Dolan G, Lee CA, Makris M, Wilde J,er al. Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma products and their impact on patients with inherited bleeding disorders. Haemophilia. 2010 Mar;16(2):30515.
Turner ML, Ludlam CA. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products. Br J Haematol. 2009 Jan;144(1):1423.
Australian researchers' discovery could lead to blood test for vCJD (12 Sept. 2012)
NEW vCJD rears up again (29 Apr. 2013)
Blood transfusions 'could spark CJD deaths'
Family of man who died from vCJD calls for reform of blood donations
DOH response: Measures currently in place in the UK to reduce the potential risk of vCJD transmission via blood | No evidence of any UK clinical cases of variant Creutzfeldt-Jakob Disease (vCJD) being linked to a blood transfusion given after 1999
UK: Could we face the return of CJD? Experts fear it may lie dormant in thousands (1 Nov. 2011)
Children to get filtered blood transfusions to beat vCJD (27 Feb. 2010)
vCJD victim with different gene suggests 2nd wave possible (18 Dec. 2009) See kaski, et al. in Journals above
CJD blood filter call for under-13s (26 Nov. 2009)
Coroners reject government plea to sample for vCJD testing during autopsies (19 Aug, 2009)
£100m blood filter treatment that stops CJD is too expensive for NHS patients (19 July 2009)
vCJD carrier risk 'overestimated' (22 May 2009)
Government committee considers limiting imported 'clean' blood to vegetarians & children amid new vCJD fears (7 Mar. 2009)
UK could import more blood to counter BSE risk from transfusions (18 Feb. 2009)
First case of vCJD in patient with hemophilia (17 Feb. 2009)
Scientists warn of 1st ever case of vCJD from plasma (14 Feb. 2009)
USA
Armed Services Blood Program expands vCJD deferral policy (9 Aug. 2011)
Health Protection Agency: Biannual CJD update
